About Eyetelligence
Eyetelligence is a company based in Roosendaal (Netherlands) founded in 2019. Eyetelligence has raised $12 million across 1 funding round from investors including Ascertain, Bupa and Aegis Ventures. Eyetelligence operates in a competitive market with competitors including Digital Diagnostics, Eyenuk, AEYE Health, DreamUp Vision and Beijing Zhiyuan Huitu Technology, among others.
- Headquarter Roosendaal, Netherlands
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$12 M (USD)
in 1 rounds
-
Latest Funding Round
$12 M (USD), Series B
May 09, 2023
-
Investors
Ascertain
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Eyetelligence
Eyetelligence has successfully raised a total of $12M through 1 strategic funding round. The most recent funding activity was a Series B round of $12 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Eyetelligence
Eyetelligence has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Ascertain, Bupa and Aegis Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Limited information is provided about Northwell Holdings and Ventures.
|
Locked | Locked | Locked | |
|
AI-based business management tool for providers
|
Locked | Locked | Locked | |
|
Health insurance and care services are provided by Bupa.
|
Locked | Locked | Locked |
Investor details for Eyetelligence
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Eyetelligence
Investment portfolio details for Eyetelligence
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Eyetelligence
Detailed financials for Eyetelligence
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Eyetelligence Comparisons
Peer comparison for Eyetelligence
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Eyetelligence
Eyetelligence operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Digital Diagnostics, Eyenuk, AEYE Health, DreamUp Vision and Beijing Zhiyuan Huitu Technology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-based disease diagnostic tools for providers
|
|
| Locked | Locked | Locked |
AI-driven retinal image analysis for diabetic retinopathy detection is developed.
|
|
| Locked | Locked | Locked |
AI-based retinal imaging software is provided for eye diagnosis.
|
|
| Locked | Locked | Locked |
Artificial Intelligence for retinal diseases
|
|
| Locked | Locked | Locked |
AI based platform for ophthalmic diagnosis and treatment
|
Detailed competitors of Eyetelligence
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Eyetelligence
Complete news archive for Eyetelligence
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eyetelligence
Eyetelligence was founded in 2019 and raised its 1st funding round 4 years after it was founded.
Eyetelligence is headquartered in Roosendaal, Netherlands. It is registered at Roosendaal, Noord-brabant, Netherlands.
Rainer Grote is the current CEO of Eyetelligence.
Eyetelligence is a funded company, having raised a total of $12M across 1 funding round to date.
AI-based clinical decision-making tool for healthacre professionals. The company has developed software that assists with analyses of retinal images. It has features for patient retinal images data management, visual tools, and more.
Eyetelligence's top competitors include Eyenuk, AEYE Health and Digital Diagnostics.
Eyetelligence has 4 investors. Key investors include Ascertain, Bupa, Aegis Ventures, and Northwell Holdings and Ventures.